All three of these growth stocks are poised to put up big gains once more investors land on the same page as investment bank analysts who follow them.
Compare AMRS Stock to Peers
|Symbol||Last Price||Market Cap||% Δ 1 Yr||% Δ 5 Yr|
News & Analysis: Amyris
The company announced promising results from a study of its experimental intranasal COVID-19 vaccine.
The flashy synthetic-biology start-up ran into a wall that Amyris has already learned how to climb over.
AMRS earnings call for the period ending June 30, 2021.
Shares of these overlooked gems could make investors very rich once the rest of the market notices their value.
One of these things is (no longer) like the others.
AMRS earnings call for the period ending March 31, 2021.
AMRS earnings call for the period ending December 31, 2020.
It could have been a lot worse.
The company has responded to a $881 million lawsuit brought against it yesterday.